Investors are overlooking Jiangsu Gdk Biological Technology'...
Investors are overlooking Jiangsu Gdk Biological Technology's recent poor growth, hoping for a business turnaround. However, unless conditions improve significantly, the share price may be hard to accept as fair value.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more